<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01623882</url>
  </required_header>
  <id_info>
    <org_study_id>041311</org_study_id>
    <nct_id>NCT01623882</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Pressure Wound Therapy System</brief_title>
  <acronym>OG/SNaP</acronym>
  <official_title>Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Negative Pressure Wound Therapy System for Treatment of Non-responding Venous Stasis and Diabetic Lower Extremity Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>KCI USA, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Organogenesis</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>KCI USA, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to evaluate the safety and efficacy of the concurrent&#xD;
      use of Apligraf® and the SNaP® Wound Care System for the treatment of diabetic and venous&#xD;
      stasis lower extremity ulcers.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    The study was terminated by Spiracur (original sponsor). Efforts were made to contact the&#xD;
    PI/study team members, but were unsuccessful.&#xD;
  </why_stopped>
  <start_date type="Actual">June 2012</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of wounds closed</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Diabetic Foot Ulcer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with lower extremity venous and diabetic ulcers.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Wound &lt; 10 cm in greatest diameter&#xD;
&#xD;
          -  Wound age &gt; 4 weeks and patient shows &lt; 50% wound area healing after 4 weeks of&#xD;
             treatment&#xD;
&#xD;
          -  Patient &gt; 18 years of age&#xD;
&#xD;
          -  Patient is willing and able to sign consent&#xD;
&#xD;
          -  Patient is willing and able to complete study visits and comply with study dressing&#xD;
             protocols&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Wound size reduction of &gt; 50% in last 4 weeks of treatment&#xD;
&#xD;
          -  Patients with active wound infections, including cellulitis and osteomyelitis&#xD;
&#xD;
          -  Patients with wounds not able to have eschar debrided&#xD;
&#xD;
          -  ABI &lt; 0.65 or SPP &lt; 30mmHg&#xD;
&#xD;
          -  Patients with wounds in anatomic areas which preclude achieving an airtight seal for&#xD;
             NPWT&#xD;
&#xD;
          -  Ulcers due to inflammatory conditions such as rheumatoid arthritis, lupus,&#xD;
             scleroderma, vasculitis, calciphylaxis, etc.&#xD;
&#xD;
          -  Patients with allergy to or intolerance of any of the wound dressing materials&#xD;
             expected to be used during the trial.&#xD;
&#xD;
          -  Pregnant patients&#xD;
&#xD;
          -  Patients unable to tolerate NPWT&#xD;
&#xD;
          -  Patients with dialysis dependent ESRD&#xD;
&#xD;
          -  Index ulcer is on the plantar surface of the foot&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Schubart, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>O'Connor Hospital</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>June 18, 2012</study_first_submitted>
  <study_first_submitted_qc>June 19, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 20, 2012</study_first_posted>
  <last_update_submitted>September 3, 2020</last_update_submitted>
  <last_update_submitted_qc>September 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes Mellitus</keyword>
  <keyword>Wounds</keyword>
  <keyword>Ulcers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

